News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Teck reported Q2 adjusted EBITDA of CAD 2.2 billion.
  • Teck posted adjusted profit attributable of CAD 948 million.
  • Higher copper production and record copper prices drove Teck's results.
  • Teck advanced its planned merger with Anglo American.
  • Renesas acquired Wolfspeed assets, positioning for automotive and power semiconductor growth.
  • Analyst upgraded Renesas to Buy, targeting a mid-term rebound to $15.50.

Latest Articles

Netskope Joins Anthropic’s Project Glasswing

Netskope Joins Anthropic’s Project Glasswing

Netskope (NASDAQ: NTSK) has joined Anthropic's Project Glasswing, leveraging Anthropic’s advanced AI model, Mythos Preview, to detect vulnerabilities in code swiftly and at scale. This collaboration enhances Netskope's ability to provide real-time governance and security across AI applications and enterprise traffic, addressing critical gaps in AI …

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte, Inc. announced the dosing of the first participant in its Phase 1 clinical trial evaluating VAX-A1, a novel vaccine candidate designed to prevent diseases caused by Group A Streptococcus (Group A Strep). This dose-escalation study aims primarily to assess safety and tolerability, with secondary evaluation of immune response in healthy adul…

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma announced key changes to its board of directors as part of its strategic evolution toward becoming a late-stage clinical company. Four independent directors resigned, and the company appointed Daniel Camardo, an experienced CEO with commercial launch success, and Viola Meehan, a seasoned CFO with extensive finance and governance exper…

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Corp., a clinical-stage biotechnology company focused on cancer immunotherapies, announced the closing of a best-efforts offering of approximately 1.45 million common shares at $3.25 per share, raising gross proceeds of about $4.7 million. The funds will be used for working capital, general corporate purposes, and advancing bu…

No-Audit Agreement Stands as Weaponization Fund Is Paused, Sources Say

No-Audit Agreement Stands as Weaponization Fund Is Paused, Sources Say

Two sources said the Justice Department’s pact shielding President Donald Trump and his family from future tax audits remains intact even as his $1.8 billion anti-weaponization fund has been placed on hold. White House officials made calls to lawmakers to assert there would be no payouts after a Republican backlash, but lawmakers are pressing for a…

Empire Petroleum Director Purchases Stock Amid Valuation Questions

Empire Petroleum Director Purchases Stock Amid Valuation Questions

A director at Empire Petroleum Corp (NASDAQ:EP) recently acquired a significant block of the company's common stock. This insider purchase occurs while the stock has seen a substantial decline over the past year. Furthermore, the company reported a first-quarter loss and lower production output, presenting a mixed picture for investors.

Kaltura Executive Executes Stock Sale Despite Recent Earnings Beat

Kaltura Executive Executes Stock Sale Despite Recent Earnings Beat

Chief Customer Officer Natan Israeli sold a block of Kaltura common stock through a pre-arranged trading plan. This activity occurred amidst mixed signals for the company, as recent Q1 2026 revenue surpassed analyst expectations, yet the stock experienced declines in aftermarket trading, suggesting cautious investor sentiment.

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Syndax Pharmaceuticals showcased new data at ASCO 2026 demonstrating favorable outcomes for Revuforj (revumenib) as maintenance therapy post hematopoietic stem cell transplant in patients with high-risk acute leukemias. The pooled analysis of 24 patients revealed a 90% two-year overall survival, nearly doubling the historical benchmark of 51%. Addi…

PDF Solutions® Announces PDF Solutions CONNECT 2026 Conference

PDF Solutions® Announces PDF Solutions CONNECT 2026 Conference

PDF Solutions, Inc. has announced it will host its CONNECT 2026 conference on October 15-16, 2026, in San Francisco, focusing on AI-driven analytics and collaboration in semiconductor manufacturing. The event will feature keynotes, demos, and presentations highlighting advancements in AI platforms that enable scalable, data-driven solutions for nex…

J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility

J-Star Holding Outlines Foundational Milestones Supporting Proposed Baytown Battery Manufacturing Facility

J-Star Holding announced significant progress for its proposed $122.5 million solid-state battery manufacturing facility in Baytown, Texas, including Taiwan Central Bank authorization for $60 million outbound investment and a formal site commitment from Baytown West Chambers County Economic Development Foundation. These developments enhance capital…